Cannprisma Magazine First Edition

Dear Valued Partners,?

We stand here with you today to tell you a story, the Cannprisma Story, where a humble plant dreamed of becoming a powerful medicine...?

As we continue to strive for excellence in the medical cannabis industry, we are excited to share the remarkable journey of Cannprisma with you. Our story is one of dedication, innovation, and a relentless commitment to quality.?

This story will be told in 4 chapters, guiding you through our journey from the very beginning until the medical cannabis hub you know today.

Chapter 1: Planting the Seeds of Innovation

1. Establishment of Cannprisma - September 2018

Our journey began in September 2018, driven by a bold vision to transform societal perceptions of cannabis. We faced numerous challenges, but our unwavering belief that breaking the stigma could revolutionize the medical cannabis industry kept us motivated.

?

?From the start, our mission was clear: to provide high-quality, scientifically backed cannabis products that enhance the health and well-being of patients in need. This foundational step set the stage for all our future achievements.?

Our Vision: To be a beacon of quality and trust in an industry filled with misinformation.?

In those early days, our team was driven by a shared belief in the potential of cannabis to transform lives. We focused on the science and the stories of patients who had found relief through medical cannabis.?

We wanted to create a company? that not only produced exceptional products but also fostered a community of education and acceptance.

?

?

?2. Start of the Manufacturing Unit Construction - December 2020

?Understanding the necessity for a state-of-the-art facility, we embarked on constructing our manufacturing unit in December 2020. We knew that merely focusing on cultivation wouldn't suffice to significantly impact the medical cannabis industry or transform patients' lives.

?

?Recognizing that our cultivation capacity alone wouldn't suffice to change the lives of all patients across Europe, we took a bold step.?

We invested in the construction and adaptation of an old lithographic printing facility. From the remnants of the previous facility, we envisioned creating a factory that could become a beacon of hope for medical cannabis patients.?

This investment laid the groundwork for scalable and efficient production processes, marking our first step toward becoming a European Medical Cannabis Hub.

3. Obtaining the License to Grow Cannabis for Medical Purposes by GACP Standards - August 2021

?

?

In August 2021, we achieved a crucial milestone by obtaining the GACP (Good Agricultural and Collection Practice) license. This certification validated our cultivation practices and aligned them with international standards, marking a significant step in our commitment to producing safe and effective medical cannabis.

? GACP ensures that plants are cultivated and collected in a way that meets the highest quality standards for raw agriculture products.

? This license allowed us to make a profound difference in patients' lives from the very first moment in the cannabis-based medicines production cycle. It represented the most personal way for us to deliver our effort, care, and empathy directly to the patient.

?

?As we reflect on these foundational milestones, we are filled with pride and gratitude for the journey so far. But this is just the beginning!?

In the next chapter, we will explore the exciting moment when we inaugurated our cultivation unit, marking the start of a new era for Cannprisma and our team. Stay tuned to discover how we continued to innovate and push boundaries in the medical cannabis industry, including obtaining the CUMCS certification and expanding our cultivation unit to meet the growing European demand for premium cannabis flowers.?

We look forward to sharing more of this incredible journey with you.

Have questions about our journey?

We'd love to hear from you, share your thoughts below!

?

?

?